| Karen Moosvi, PHD, APN | |
|
28 Crine Road, Colts Neck, NJ 07722-1410 | |
| (732) 682-7716 | |
| Not Available |
| Full Name | Karen Moosvi |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Adult |
| Location | 28 Crine Road, Colts Neck, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568691269 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0809X | Clinical Nurse Specialist - Psychiatric/mental Health, Adult | 26NC06020900 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karen Moosvi, PHD, APN 28 Crine Road, Colts Neck, NJ 07722-1410 Ph: (732) 682-7716 | Karen Moosvi, PHD, APN 28 Crine Road, Colts Neck, NJ 07722-1410 Ph: (732) 682-7716 |
News Archive
New research suggests that the pharmacological effects of taking medications such as statins and beta-blockers as prescribed following a heart attack is associated with living longer, according to a study in the January 10 issue of JAMA: The Journal of the American Medical Association.
An FDA advisory panel has declared that an over-the-counter weight-loss drug appears to be safe and effective for a six month period of use.
The Mississippi bill, which would require doctors working at abortion clinics to have admitting privileges to a local hospital, passed the House last month and is expected to be signed by the governor. Meanwhile, 32 Republican lawmakers in Arizona received knitted uteruses as part of a national protest against government regulation of women's health.
Funded by the National Institutes of Health, six U.S. research institutions are launching the first-ever multicenter network to study diabetic foot ulcers, a common and burdensome complication of diabetes and the leading cause of lower limb amputations in the United States.
Amneal Pharmaceuticals LLC today announced the launch of generic Esomeprazole strontium delayed-release capsules 49.3 mg. This new esomeprazole therapy is the generic equivalent of the recently launched brand Esomeprazole strontium. It contains the same active moiety (esomeprazole) in a different salt form as found in the leading PPI brand Nexium (esomeprazole magnesium) and presents a potentially more affordable treatment option for GERD in adult patients.
› Verified 9 days ago